About 40% of people with non-small cell lung cancer (NSCLC)—a type of cancer that begins in the tissues of your lungs—have metastatic disease at the time of their diagnosis. Metastatic NSCLC refers to ...
Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...
New York Times media columnist David Carr died of complications from metastatic lung cancer, according to autopsy results released Saturday. The autopsy shows heart disease also contributed to his ...
The HER2CLIMB-05 study assessed the efficacy and safety of adding tucatinib to maintenance therapy with trastuzumab/pertuzumab in patients with HER2+ metastatic breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback